BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Prognosis
18 results:

  • 1. EIF3B promotes cancer progression in pancreatic cancer.
    Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
    Scand J Gastroenterol; 2021 Mar; 56(3):281-288. PubMed ID: 33459066
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Reduced expression of the RNA-binding protein HuD in pancreatic neuroendocrine tumors correlates with low p27
    Kim C; Jeong DE; Heo S; Ji E; Rho JG; Jung M; Ahn S; Kim YJ; Kim YS; Nam SW; Kulkarni RN; Lee KB; Lee EK; Kim W
    J Pathol; 2018 Oct; 246(2):231-243. PubMed ID: 30014466
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen.
    Kurahara H; Bohl C; Natsugoe S; Nishizono Y; Harihar S; Sharma R; Iwakuma T; Welch DR
    Int J Cancer; 2016 Aug; 139(3):628-38. PubMed ID: 27012470
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
    Zhao Z; Li C; Xi H; Gao Y; Xu D
    Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cyclin D1, p16(INK) (4A) and p27(kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis.
    Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
    APMIS; 2014 Dec; 122(12):1230-9. PubMed ID: 25053516
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Efemp1 and p27(kip1) modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models.
    Diersch S; Wenzel P; Szameitat M; Eser P; Paul MC; Seidler B; Eser S; Messer M; Reichert M; Pagel P; Esposito I; Schmid RM; Saur D; Schneider G
    Oncotarget; 2013 Feb; 4(2):277-88. PubMed ID: 23470560
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ZD1839 (IRESSA) stabilizes p27kip1 and enhances radiosensitivity in cholangiocarcinoma cell lines.
    Yabuuchi S; Katayose Y; Oda A; Mizuma M; Shirasou S; Sasaki T; Yamamoto K; Oikawa M; Rikiyama T; Onogawa T; Yoshida H; Ohtuska H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2009 Apr; 29(4):1169-80. PubMed ID: 19414361
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Progression elevated gene-3 promoter (PEG-Prom) confers cancer cell selectivity to human polynucleotide phosphorylase (hPNPase(old-35))-mediated growth suppression.
    Chan I; Lebedeva IV; Su ZZ; Sarkar D; Valerie K; Fisher PB
    J Cell Physiol; 2008 May; 215(2):401-9. PubMed ID: 17960560
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.
    Kouvaraki MA; Korapati AL; Rassidakis GZ; Tian L; Zhang Q; Chiao P; Ho L; Evans DB; Claret FX
    Cancer Res; 2006 Sep; 66(17):8581-9. PubMed ID: 16951171
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
    Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
    Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic significance of localized p27kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Fukumoto A; Ikeda N; Sho M; Tomoda K; Kanehiro H; Hisanaga M; Tsurui Y; Tsutsumi M; Kato JY; Nakajima Y
    Oncol Rep; 2004 Feb; 11(2):277-84. PubMed ID: 14719054
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer.
    Juuti A; Nordling S; Louhimo J; Lundin J; von Boguslawski K; Haglund C
    Oncology; 2003; 65(4):371-7. PubMed ID: 14707458
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.
    Itami A; Watanabe G; Shimada Y; Hashimoto Y; Kawamura J; Kato M; Hosotani R; Imamura M
    Int J Cancer; 2001 Nov; 94(3):370-6. PubMed ID: 11745416
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. p27(kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis.
    Hui AM; Li X; Shi YZ; Torzilli G; Takayama T; Makuuchi M
    Hepatology; 2000 May; 31(5):1068-72. PubMed ID: 10796881
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Decreased p27(kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
    Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
    Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Loss of p27kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma.
    Lu CD; Morita S; Ishibashi T; Hara H; Isozaki H; Tanigawa N
    Cancer; 1999 Mar; 85(6):1250-60. PubMed ID: 10189129
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.